tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RNAC Stock Latest News

Cartesian receives FDA Rare Pediatric Disease Designation for Descartes-08
The FlyCartesian receives FDA Rare Pediatric Disease Designation for Descartes-08
11d ago
RNAC
Cartesian Therapeutics announces employment inducement grant
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grant
14d ago
RNAC
Cartesian Therapeutics Announces New Employment Inducement Grant
PremiumPress Releases
Cartesian Therapeutics Announces New Employment Inducement Grant
14d ago
RNAC
Cartesian announces first patient dosed in Phase 1 trial of Descartes-15
PremiumThe Fly
Cartesian announces first patient dosed in Phase 1 trial of Descartes-15
17d ago
RNAC
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
PremiumPress Releases
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
17d ago
RNAC
Cartesian Therapeutics price target lowered to $45 from $49 at H.C. Wainwright
PremiumThe FlyCartesian Therapeutics price target lowered to $45 from $49 at H.C. Wainwright
1M ago
RNAC
Cartesian Therapeutics Engages Investors at Conferences
Premium
Company Announcements
Cartesian Therapeutics Engages Investors at Conferences
1M ago
8K
RNAC
Cartesian Therapeutics reports Q2 EPS 54c, consensus ($1.07)
Premium
The Fly
Cartesian Therapeutics reports Q2 EPS 54c, consensus ($1.07)
1M ago
RNAC
Cartesian Therapeutics Announces New Employment Inducement Grants
PremiumPress Releases
Cartesian Therapeutics Announces New Employment Inducement Grants
1M ago
RNAC
Nvidia, Crowdstrike upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nvidia, Crowdstrike upgraded: Wall Street’s top analyst calls
1M ago
O
CG
Cartesian Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
Cartesian Therapeutics initiated with a Buy at TD Cowen
2M ago
RNAC
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
ACET
ALLO
Cartesian Therapeutics Announces New Employment Inducement Grants
PremiumPress ReleasesCartesian Therapeutics Announces New Employment Inducement Grants
2M ago
RNAC
Cartesian Therapeutics price target raised to $43 from $38 at Canaccord
Premium
The Fly
Cartesian Therapeutics price target raised to $43 from $38 at Canaccord
3M ago
RNAC
Cartesian Therapeutics price target lowered to $49 from $54 at H.C. Wainwright
Premium
The Fly
Cartesian Therapeutics price target lowered to $49 from $54 at H.C. Wainwright
3M ago
RNAC
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
PremiumPress Releases
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
3M ago
RNAC
Cartesian Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Cartesian Therapeutics downgraded to Perform from Outperform at Oppenheimer
3M ago
RNAC
Cartesian Therapeutics: Investment, Director Appointment, and Trial Success
PremiumCompany Announcements
Cartesian Therapeutics: Investment, Director Appointment, and Trial Success
3M ago
8K
RNAC
Cartesian Therapeutics announces $130M private placement equity financing
PremiumThe Fly
Cartesian Therapeutics announces $130M private placement equity financing
3M ago
RNAC
Cartesian says first patient dosed in Phase 2 trial of Descartes-08 in SLE
PremiumThe FlyCartesian says first patient dosed in Phase 2 trial of Descartes-08 in SLE
3M ago
RNAC
Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis
Premium
Press Releases
Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis
3M ago
RNAC
Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
Premium
Press Releases
Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
3M ago
RNAC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >